The results showed that daily supplementation with 180 milligrams of pure ellagic acid in MS patients decreased the level of inflammatory cytokines, including IL-17 and IFNγ, and increased the serum level of anti-inflammatory cytokines, including IL-4. Here, IFNG is linked to myeloid sarcoma.